<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00032591</url>
  </required_header>
  <id_info>
    <org_study_id>481</org_study_id>
    <nct_id>NCT00032591</nct_id>
  </id_info>
  <brief_title>The Home INR Study</brief_title>
  <acronym>THINRS</acronym>
  <official_title>CSP #481 - The Home INR Study (THINRS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since home monitors of prothrombin time (PT) may potentially improve the safety, quality, and
      convenience of chronic anticoagulation management, it is likely that there will be demands
      from providers, patients, and manufacturers to make home monitors available to VA patients.
      The rationale for patient self-testing (PST) is that, compared to conventional high quality
      anticoagulation management (HQACM), it would permit more intense monitoring and increased
      patient participation in his/her own care, resulting in increased precision in
      anticoagulation control and thus fewer events of thromboembolism (strokes) and bleeding. The
      secondary hypothesis is that PST and HQACM will be comparable in terms of health care
      utilization and cost.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intervention: Weekly patient self-testing (PST) of prothrombin time by international
      normalized ratio (PT INR) versus conventional monthly high quality anticoagulation management
      (HQACM) from an anticoagulation clinic with a minimum two years follow-up.

      Primary Hypothesis: Compared to conventional monitoring in the clinic, PST of anticoagulation
      intensity will decrease the number of events of thromboembolism (strokes), bleeding, and all
      cause deaths and improve the quality of anticoagulation.

      Second Hypothesis: PST and conventional monitoring will be comparable in terms of health care
      utilization and cost.

      Primary Outcomes: Event rates (thromboembolism or bleeding episodes), time to first event,
      time within therapeutic range for anticoagulation intensity, and total health care cost
      (including price of PST monitors) and utilization.

      Study Abstract: Since home monitors of prothrombin time (PT) may potentially improve the
      safety, quality, and convenience of chronic anticoagulation management, it is likely that
      there will be demands from providers, patients, and manufacturers to make home monitors
      available to VA patients. The rationale for PST is that it would permit more intense
      monitoring and increased patient participation in his/her own care, resulting in increased
      precision in anticoagulation control and thus fewer events.

      Original plan was for a study at 32 sites with a total sample size of about 3,200 patients
      and a length of three years (one for recruitment and two years of follow-up). Final status
      was 28 sites that randomized 2922 patients in 2.75 years of recruitment with a minimum of two
      years of follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to First Event (Death, Stroke, Major Bleed)</measure>
    <time_frame>Time to event</time_frame>
    <description>Time to first event (death, stroke, major bleed)
The primary outcome was time to first event, and we used the Kaplan-Meier method to compare survival curves and the results using the log-rank test. The number of patients with a primary outcome is what was reported in the NEJM paper. Below is the unpublished cumulative incidence information.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time in Therapeutic Range Over Full Length of Follow-up (0 to 100 Percent)</measure>
    <time_frame>Full length of follow-up; average of 3 years</time_frame>
    <description>Time in target range (TTR) based on Prothrombin Time standardized to the International Normalized Ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DASS at 2 Years of Follow-up</measure>
    <time_frame>At two years of follow-up</time_frame>
    <description>Satisfaction with care was quantified using the Duke Anticoagulation Satisfaction Scale (DASS). Scores range from 25 to 225, with lower scores indicating higher satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Gain in Health Utilities at 2 Year</measure>
    <time_frame>After 2 years of follow-up for each subject</time_frame>
    <description>Scores range from -0.36 to 1.00 per year, with a negative score indicating a state worse than being dead and a score of 1.00 indicating perfect health. Since the time frame is 2 years, the range is -0.72 to 2.00.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Costs at 2 Year</measure>
    <time_frame>After 2 years of follow-up for each subject</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2922</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Weekly patient self-testing of prothrombin time</intervention_name>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High quality anticoagulation management (HQACM) with conventional monthly testing</intervention_name>
    <description>HQACM with testing every 4 weeks and as indicated for out of range values, medication/clinical changes.</description>
    <arm_group_label>Arm 2</arm_group_label>
    <other_name>HQACM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        To be enrolled in this study, patients must:

          1. have AF and/or a MHV;

          2. be scheduled to receive warfarin indefinitely (operationally defined as 2 years);

          3. be using warfarin according to the criteria described in the Coumadin package insert
             (no off-label uses);

          4. be expected to survive for the duration of the study;

          5. not be suffering from intracranial bleeding (intracranial hemorrhage, subarachnoid
             hemorrhage, hemorrhagic stroke) or any other contraindication described in the
             Coumadin package insert;

          6. be willing to perform PST;

          7. be willing to be randomized;

          8. possess adequate cognitive and language skills to follow the protocol and all related
             instructions;

          9. be willing to participate for the full duration of the study;

         10. sign the informed consent form; and

         11. not be enrolled in another randomized clinical trial that involves a drug or device
             intervention.

        Exclusion Criteria:

        Patients are excluded in this study if:

          1. subject has had intracranial hemorrhage, subarachnoid hemorrhage, hemorrhagic stroke,
             or any other absolute/major contraindication described in the warfarin package insert
             within the last month

          2. subject enrolled in another randomized clinical trial that involves a drug or device
             intervention

          3. subject is not able to follow the protocol and all related instructions, and does not
             have a caregiver with these skills
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David B. Matchar, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Durham VA Medical Center HSR&amp;D COE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Medical Center, Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Central California Health Care System, Fresno</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Loma Linda</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92357</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West LA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Eastern Colorado Health Care System, Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Connecticut Health Care System (West Haven)</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edward Hines, Jr. VA Hospital</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141-5000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, North Chicago</name>
      <address>
        <city>North Chicago</city>
        <state>Illinois</state>
        <zip>60064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Iowa City</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52246-2208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Maryland Health Care System, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John D. Dingell VA Medical Center, Detroit</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Kansas City MO</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Las Vegas</name>
      <address>
        <city>North Las Vegas</city>
        <state>Nevada</state>
        <zip>89036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Sierra Nevada Health Care System</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Bronx</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Western New York Healthcare System at Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Syracuse</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durham VA Medical Center HSR&amp;D COE</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Oklahoma City</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Pittsburgh Health Care System</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Providence</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA North Texas Health Care System, Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA South Texas Health Care System, San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Salem VA</name>
      <address>
        <city>Salem</city>
        <state>Virginia</state>
        <zip>24153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wlliam S. Middleton Memorial Veterans Hospital, Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, San Juan</name>
      <address>
        <city>San Juan</city>
        <zip>00921</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Dolor RJ, Ruybalid RL, Uyeda L, Edson RG, Phibbs C, Vertrees JE, Shih MC, Jacobson AK, Matchar DB; THINRS Site Investigators. An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS). J Thromb Thrombolysis. 2010 Oct;30(3):263-75. doi: 10.1007/s11239-010-0499-8.</citation>
    <PMID>20628787</PMID>
  </results_reference>
  <results_reference>
    <citation>Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS, Vertrees JE, Shih MC, Holodniy M, Lavori P; THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010 Oct 21;363(17):1608-20. doi: 10.1056/NEJMoa1002617. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93.</citation>
    <PMID>20961244</PMID>
  </results_reference>
  <results_reference>
    <citation>Matchar DB, Jacobson AK, Edson RG, Lavori PW, Ansell JE, Ezekowitz MD, Rickles F, Fiore L, Boardman K, Phibbs C, Fihn SD, Vertrees JE, Dolor R. The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS). J Thromb Thrombolysis. 2005 Jun;19(3):163-72.</citation>
    <PMID>16082603</PMID>
  </results_reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2002</study_first_submitted>
  <study_first_submitted_qc>March 27, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2002</study_first_posted>
  <results_first_submitted>June 12, 2013</results_first_submitted>
  <results_first_submitted_qc>December 24, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 6, 2014</results_first_posted>
  <last_update_submitted>March 18, 2014</last_update_submitted>
  <last_update_submitted_qc>March 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AF</keyword>
  <keyword>Mechanical heart valve (MHV)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment started in August 2003 and ended at the end of May 2006. Participating sites were VA Medical Centers with anticoagulation services with active rosters of more than 400 patients.</recruitment_details>
      <pre_assignment_details>A total of 3745 participants were consented and screened. Out of this total, 823 were excluded from the study. The majority of those excluded is due to participants not doing or passing the competency assessment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Patient Self-Testing (PST)</title>
          <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
        </group>
        <group group_id="P2">
          <title>High Quality Anticoagulation Management (HQACM)</title>
          <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Screening</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1873">3745 patients provided informed consent and were screened for participation.</participants>
                <participants group_id="P2" count="1872">Treatment assigned at randomization; screening counts by arm represent half of the total screened.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1465">823 were excluded from the study</participants>
                <participants group_id="P2" count="1457"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="408"/>
                <participants group_id="P2" count="415"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Randomization</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1465">2922 underwent randomization</participants>
                <participants group_id="P2" count="1457"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1465">1465 were assigned to self-testing</participants>
                <participants group_id="P2" count="1457">1457 were assigned to clinic testing</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1465">2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves</participants>
                <participants group_id="P2" count="1457">5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1463">1463 were included in analysis with greater than 1 day of follow-up</participants>
                <participants group_id="P2" count="1452">1452 were included in analysis with greater than 1 day of follow-up</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>3745 participants were screened for participation</population>
      <group_list>
        <group group_id="B1">
          <title>Patient Self-Testing (PST)</title>
          <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
        </group>
        <group group_id="B2">
          <title>High Quality Anticoagulation Management (HQACM)</title>
          <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1465"/>
            <count group_id="B2" value="1457"/>
            <count group_id="B3" value="2922"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Total study population</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.6" spread="9.7"/>
                    <measurement group_id="B2" value="67.4" spread="9.4"/>
                    <measurement group_id="B3" value="67" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1440"/>
                    <measurement group_id="B2" value="1431"/>
                    <measurement group_id="B3" value="2871"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to First Event (Death, Stroke, Major Bleed)</title>
        <description>Time to first event (death, stroke, major bleed)
The primary outcome was time to first event, and we used the Kaplan-Meier method to compare survival curves and the results using the log-rank test. The number of patients with a primary outcome is what was reported in the NEJM paper. Below is the unpublished cumulative incidence information.</description>
        <time_frame>Time to event</time_frame>
        <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Self-Testing (PST)</title>
            <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
          </group>
          <group group_id="O2">
            <title>High Quality Anticoagulation Management (HQACM)</title>
            <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Event (Death, Stroke, Major Bleed)</title>
          <description>Time to first event (death, stroke, major bleed)
The primary outcome was time to first event, and we used the Kaplan-Meier method to compare survival curves and the results using the log-rank test. The number of patients with a primary outcome is what was reported in the NEJM paper. Below is the unpublished cumulative incidence information.</description>
          <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
          <units>cumulative probability of event</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1463"/>
                <count group_id="O2" value="1452"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cumulative Incidence at 500 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0785" lower_limit="0.0645" upper_limit="0.0925"/>
                    <measurement group_id="O2" value="0.0987" lower_limit="0.0830" upper_limit="0.1144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cumulative Incidence at 1000 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1542" lower_limit="0.1349" upper_limit="0.1734"/>
                    <measurement group_id="O2" value="0.1820" lower_limit="0.1610" upper_limit="0.2031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cumulative Incidence at 1500 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2268" lower_limit="0.2002" upper_limit="0.2535"/>
                    <measurement group_id="O2" value="0.2524" lower_limit="0.2229" upper_limit="0.2818"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis was the hazard ratio was equal to 1.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A target of 363 patients with primary events required to discern a 32% relative drop in annual primary event rates with 90% power (from 5.5% for HQACM to 3.75% for PST) was based on a sample size of 3200 patients with 1 year of enrollment and a minimum of 2 years follow-up. Due to slower than planned enrollment, we randomized 2922 patients over 2.75 years, with a mean follow-up of 3 years.</non_inferiority_desc>
            <p_value>0.14</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.88</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time in Therapeutic Range Over Full Length of Follow-up (0 to 100 Percent)</title>
        <description>Time in target range (TTR) based on Prothrombin Time standardized to the International Normalized Ratio</description>
        <time_frame>Full length of follow-up; average of 3 years</time_frame>
        <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Self-Testing (PST)</title>
            <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
          </group>
          <group group_id="O2">
            <title>High Quality Anticoagulation Management (HQACM)</title>
            <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
          </group>
        </group_list>
        <measure>
          <title>Time in Therapeutic Range Over Full Length of Follow-up (0 to 100 Percent)</title>
          <description>Time in target range (TTR) based on Prothrombin Time standardized to the International Normalized Ratio</description>
          <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1463"/>
                <count group_id="O2" value="1452"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.2" spread="14.2"/>
                    <measurement group_id="O2" value="62.4" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>DASS at 2 Years of Follow-up</title>
        <description>Satisfaction with care was quantified using the Duke Anticoagulation Satisfaction Scale (DASS). Scores range from 25 to 225, with lower scores indicating higher satisfaction.</description>
        <time_frame>At two years of follow-up</time_frame>
        <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Self-Testing (PST)</title>
            <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
          </group>
          <group group_id="O2">
            <title>High Quality Anticoagulation Management (HQACM)</title>
            <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
          </group>
        </group_list>
        <measure>
          <title>DASS at 2 Years of Follow-up</title>
          <description>Satisfaction with care was quantified using the Duke Anticoagulation Satisfaction Scale (DASS). Scores range from 25 to 225, with lower scores indicating higher satisfaction.</description>
          <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1120"/>
                <count group_id="O2" value="929"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.8" spread="16.3"/>
                    <measurement group_id="O2" value="49.2" spread="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cumulative Gain in Health Utilities at 2 Year</title>
        <description>Scores range from -0.36 to 1.00 per year, with a negative score indicating a state worse than being dead and a score of 1.00 indicating perfect health. Since the time frame is 2 years, the range is -0.72 to 2.00.</description>
        <time_frame>After 2 years of follow-up for each subject</time_frame>
        <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Self-Testing (PST)</title>
            <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
          </group>
          <group group_id="O2">
            <title>High Quality Anticoagulation Management (HQACM)</title>
            <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Gain in Health Utilities at 2 Year</title>
          <description>Scores range from -0.36 to 1.00 per year, with a negative score indicating a state worse than being dead and a score of 1.00 indicating perfect health. Since the time frame is 2 years, the range is -0.72 to 2.00.</description>
          <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1183"/>
                <count group_id="O2" value="997"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.204" spread="0.619"/>
                    <measurement group_id="O2" value="1.049" spread="0.575"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Care Costs at 2 Year</title>
        <time_frame>After 2 years of follow-up for each subject</time_frame>
        <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Self-Testing (PST)</title>
            <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
          </group>
          <group group_id="O2">
            <title>High Quality Anticoagulation Management (HQACM)</title>
            <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
          </group>
        </group_list>
        <measure>
          <title>Health Care Costs at 2 Year</title>
          <population>Randomized participants with at least one day of follow-up, per intent to treat</population>
          <units>U.S. Dollars</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1463"/>
                <count group_id="O2" value="1452"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25,754" spread="35,673"/>
                    <measurement group_id="O2" value="24,505" spread="31,827"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Full length of follow-up</time_frame>
      <desc>Serious Adverse Events (SAEs) and non-serious AEs were coded using the Medical Dictionary for Regulatory Activities (MedDRA) version 6.1. The verbatim description was used to classify events by Body System affected (System Organ Class or SOC) and to group using a common medical term (Preferred Term or PT).</desc>
      <group_list>
        <group group_id="E1">
          <title>Patient Self-Testing (PST)</title>
          <description>Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing</description>
        </group>
        <group group_id="E2">
          <title>High Quality Anticoagulation Management (HQACM)</title>
          <description>High quality anticoagulation management (HQACM) with conventional monthly testing</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="247" subjects_at_risk="1465"/>
                <counts group_id="E2" subjects_affected="250" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Asystole</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac ischemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>&quot;Chronic ischemic heart disease, unspecified&quot;</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Congestive heart failure</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="1465"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>End stage heart disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Heart failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ischemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1465"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Non-Q wave MI</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Q wave MI</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous malformations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hyphema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Retinal hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Vitreous hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding esophageal ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding gastric ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bowel infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal hemorrhagic</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal hemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Duodenal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Esophageal hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastric bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastroesophageal junction ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>GI bleed</sub_title>
                <counts group_id="E1" events="30" subjects_affected="24" subjects_at_risk="1465"/>
                <counts group_id="E2" events="50" subjects_affected="33" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gum bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhage intraperitoneal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhoidal bleeding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Inflammatory bowel disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mallory Weiss tear</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Melena</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Perforation post colonoscopy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Rectal bleeding</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Retroperitoneal bleed</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ruptured appendix</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ruptured diverticulum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Strangulated hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Tongue hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>UGI bleed</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="1465"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Drug interaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Multi organ failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cellulitis of hand</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cellulitis of leg</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Endocarditis staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Infectious diarrhea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Nosocomial pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1465"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pneumonia MRSA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous fistula site bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Brain herniation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac procedure complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Chronic subdural hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Collapse of lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Explosion injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematuria traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Incision site bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intraoperative bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Motor cycling accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Motor vehicle accident</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Post biopsy bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Post procedural bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative bleeding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Radiation esophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Radiation pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Stoma site bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Subdural hematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Traumatic hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Traumatic hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Occult blood positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematoma muscle</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Joint bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute leukemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bladder squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Brain tumor</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Carcinoma duodenum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Carcinoma vocal cord</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Esophageal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhagic tumor necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hodgkin*s lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Leukemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Leukemia myelogenous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>&quot;Liver, cancer of&quot;</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lung cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Metastatic carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Metastatic colon cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Metastatic disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>&quot;Metastatic neoplasm NOS, primary site unknown&quot;</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma of the skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pancreatic adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pancreatic cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pancreatic cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sarcoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Unknown primary cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Anoxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding intracranial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Brain stem hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cerebellar hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cerebral hematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cerebral hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="1465"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhagic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypoxic brain damage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intracerebral hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intracranial hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intracranial hemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Middle cerebral artery stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Middle cerebral artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ruptured cerebral aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Subarachnoid hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1465"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Transient ischemic attacks</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Suicide</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Blood clot in urine</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Chronic renal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Renal artery aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Pelvic hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>ARDS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Aspiration pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>COPD</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>COPD exacerbation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemopneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemoptysis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemothorax</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lung mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mediastinal hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Unspecified disease of respiratory system</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Coronary artery bypass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pneumonectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Polypectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal aortic aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Arterial embolism limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Arterial hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Arteriosclerotic cardiovascular disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Atherosclerotic cardiovascular disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiovascular collapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Dissecting aortic aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Embolus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1465"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhagic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Thromboembolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="399" subjects_at_risk="1465"/>
                <counts group_id="E2" subjects_affected="332" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Non-Q wave MI</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="1465"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Q wave MI</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastrointestinal arteriovenous malformation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding from ears</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctival bleeding</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Corneal bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Eye hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intraocular hemorrhage</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ocular retrobulbar hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Scleral hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Subconjunctival hemorrhage</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Vitreous hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding from tongue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding gastric ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding lips</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding mouth</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Blood in stool</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diverticulosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>GI bleed</sub_title>
                <counts group_id="E1" events="28" subjects_affected="27" subjects_at_risk="1465"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematochezia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemoperitoneum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhoidal bleeding</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="1465"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mallory Weiss tear</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Melena</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Perforation post colonoscopy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Rectal bleeding</sub_title>
                <counts group_id="E1" events="39" subjects_affected="32" subjects_at_risk="1465"/>
                <counts group_id="E2" events="40" subjects_affected="35" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Retroperitoneal bleed</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="1465"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>UGI bleed</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Catheter site bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Catheter site hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Central line complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Injection site bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gallbladder hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Cellulitis of finger</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cellulitis of leg</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abrasions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Anemia postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Arteriovenous graft site hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bruising</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Dog bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Femoral artery injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Foot injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Incision site bleeding</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Incision site hematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intraoperative bleeding</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="1465"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="20" subjects_affected="19" subjects_at_risk="1465"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Post biopsy bleeding</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1465"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Post procedural bleeding</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="1465"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative bleeding</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1465"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative hematoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Scrotal hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Traumatic hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Venous injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Cystoscopy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Fecal occult blood</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hemarthrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematoma muscle</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Joint bleeding</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Joint hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Muscle hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Myelodysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhagic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intracranial hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="29" subjects_affected="24" subjects_at_risk="1465"/>
                <counts group_id="E2" events="41" subjects_affected="34" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding urogenital</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" events="89" subjects_affected="67" subjects_at_risk="1465"/>
                <counts group_id="E2" events="72" subjects_affected="54" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Renal artery embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Urethral hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Urinary tract bleeding</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="1465"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding genital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematospermia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Scrotal hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Testicular hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Effusion pleural bloody</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="130" subjects_affected="79" subjects_at_risk="1465"/>
                <counts group_id="E2" events="88" subjects_affected="63" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemoptysis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="1465"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhage from throat</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pleural hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory tract hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="21" subjects_affected="12" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Foot ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hemorrhage subcutaneous</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Circumcision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ileostomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" events="45" subjects_affected="32" subjects_at_risk="1465"/>
                <counts group_id="E2" events="31" subjects_affected="27" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Deep venous thrombosis arm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Deep venous thrombosis femoral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>DVT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1465"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Embolus arm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1465"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="1465"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Bob Edson</name_or_title>
      <organization>Palo Alto CSPCC</organization>
      <phone>(650) 493-5000 ext 22250</phone>
      <email>Bob.Edson@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

